Doctors and patients try to shame insurers online to reverse prior authorization denials

FHS
August 23, 2023
11:07 am

Sally Nix was furious when her health insurance company refused to pay for the infusions she needs to ease her chronic pain and fatigue.

Greece’s antitrust regulator probes Novartis over practices tied to a pricey eye drug

Greece’s antitrust regulator is investigating allegations that, over a nine-year period, Novartis paid doctors and institutions to prescribe a pricey treatment for a serious eye

September 3, 2024

Human cell-based model of thoracic aortic aneurysm offers new opportunities for drug development

Using human cells in laboratory rats, Michigan Medicine researchers have developed a functional model of thoracic aortic aneurysm, creating opportunities for more effective understanding of

May 14, 2024

SEC and Kiromic settle over biotech’s failure to disclose clinical trial holds ahead of stock offering

The SEC said Tuesday that it settled charges filed against Kiromic BioPharma, a tiny immuno-oncology startup based in Texas, for failing to disclose clinical holds

December 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.